Statistics

 array:24 [
  "pii" => "S1665268121000259"
  "issn" => "16652681"
  "doi" => "10.1016/j.aohep.2021.100326"
  "estado" => "S300"
  "fechaPublicacion" => "2021-05-01"
  "aid" => "100326"
  "copyright" => "Fundación Clínica Médica Sur, A.C."
  "copyrightAnyo" => "2021"
  "documento" => "simple-article"
  "crossmark" => 1
  "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
  "subdocumento" => "cor"
  "cita" => "Ann Hepatol. 2021;22C:"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:1 [
    "total" => 0
  ]
  "itemAnterior" => array:19 [
    "pii" => "S1665268120302209"
    "issn" => "16652681"
    "doi" => "10.1016/j.aohep.2020.100295"
    "estado" => "S300"
    "fechaPublicacion" => "2021-05-01"
    "aid" => "100295"
    "copyright" => "Fundación Clínica Médica Sur, A.C."
    "documento" => "simple-article"
    "crossmark" => 1
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "cor"
    "cita" => "Ann Hepatol. 2021;22C:"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:1 [
      "total" => 0
    ]
    "en" => array:8 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Letters to the editor</span>"
      "titulo" => "Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection &#40;COVID-19&#41;"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Xiaofei Li"
          "autores" => array:1 [
            0 => array:2 [
              "nombre" => "Xiaofei"
              "apellidos" => "Li"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268120302209?idApp=UINPBA00004N"
    "url" => "/16652681/000000220000000C/v3_202107300613/S1665268120302209/v3_202107300613/en/main.assets"
  ]
  "asociados" => array:1 [
    0 => array:19 [
      "pii" => "S1665268120302209"
      "issn" => "16652681"
      "doi" => "10.1016/j.aohep.2020.100295"
      "estado" => "S300"
      "fechaPublicacion" => "2021-05-01"
      "aid" => "100295"
      "copyright" => "Fundaci&#243;n Cl&#237;nica M&#233;dica Sur&#44; A&#46;C&#46;"
      "documento" => "simple-article"
      "crossmark" => 1
      "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
      "subdocumento" => "cor"
      "cita" => "Ann Hepatol. 2021;22C:"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:1 [
        "total" => 0
      ]
      "en" => array:8 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Letters to the editor</span>"
        "titulo" => "Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection &#40;COVID-19&#41;"
        "tienePdf" => "en"
        "tieneTextoCompleto" => "en"
        "contieneTextoCompleto" => array:1 [
          "en" => true
        ]
        "contienePdf" => array:1 [
          "en" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Xiaofei Li"
            "autores" => array:1 [
              0 => array:2 [
                "nombre" => "Xiaofei"
                "apellidos" => "Li"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "en"
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268120302209?idApp=UINPBA00004N"
      "url" => "/16652681/000000220000000C/v3_202107300613/S1665268120302209/v3_202107300613/en/main.assets"
    ]
  ]
  "en" => array:9 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Letters to the Editor</span>"
    "titulo" => "Reply to&#58; Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection &#40;COVID-19&#41;"
    "tieneTextoCompleto" => true
    "saludo" => "Dear Editor&#44;"
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Ivan L&#243;pez-Mendez, Graciela Castro-Narro"
        "autores" => array:2 [
          0 => array:4 [
            "nombre" => "Ivan"
            "apellidos" => "L&#243;pez-Mendez"
            "email" => array:1 [
              0 => "yahvelopezmendez@gmail.com"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:2 [
            "nombre" => "Graciela"
            "apellidos" => "Castro-Narro"
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:2 [
            "entidad" => "Transplants and Hepatology Unit&#44; Medica Sur Clinic &#38; Foundation&#44; Puente de Piedra 150 Toriello Guerra&#44; Tlalpan&#44; ZC 14050 Mexico City&#44; Mexico"
            "identificador" => "aff0005"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Corresponding author&#46;"
          ]
        ]
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">In response to correspondence for Xiaofei Li&#44; we appreciate the interest in our work and we have the following answers to each commentary&#46;</p><p id="par0010" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">First commentary&#58;</span></p><p id="par0015" class="elsevierStylePara elsevierViewall">Regarding to Fib4 cut-off point&#44; in our study&#44; we used cut- off point of &#62;3&#46;25&#44; which is validated in the Latin American population&#46; &#40;Ann Hepatol&#46; 2013 May&#8211;Jun&#59;12&#40;3&#41;&#58;416&#8211;24&#46; PMID&#58; 23619258&#41;&#46;</p><p id="par0020" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Second commentary&#58;</span></p><p id="par0025" class="elsevierStylePara elsevierViewall">The OR reported in our study correspond to all patients &#40;diabetics and non-diabetics&#41;&#59; however&#44; as suggested&#44; we conduct a subgroup analysis with diabetic patients&#59; results showed that in diabetic patients with high levels of glucose &#40;&#62;100<span class="elsevierStyleHsp" style=""></span>mg&#47;dL&#41; the risk of ICU admission still been higher compared to those diabetic patients with normal glucose levels&#46; It is important to consider that despite previous diabetes diagnosis&#44; an increase in glucose levels could be caused by systemic inflammatory response syndrome&#46;</p><p id="par0030" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Third commentary&#58;</span></p><p id="par0035" class="elsevierStylePara elsevierViewall">Regarding obesity&#44; despite the high worldwide and Mexico prevalence&#44; our population is majorly overweight&#44; being 30<span class="elsevierStyleHsp" style=""></span>kg&#47;m<span class="elsevierStyleSup">2</span> the cut-off point for obesity in the Mexican population&#59; this distribution and sample size could explain the absence of significative statistical association with clinical outcomes&#46; Nevertheless&#44; the presence of obesity needs to be evaluated in the assessment of COVID-19 patients&#44; especially in those with other metabolic comorbidities&#46;</p><p id="par0040" class="elsevierStylePara elsevierViewall">All the authors appreciate the author&#39;s time invested in our manuscript&#46; If you need further information&#44; please contact us&#46;</p></span>"
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
  ]
  "idiomaDefecto" => "en"
  "url" => "/16652681/000000220000000C/v3_202107300613/S1665268121000259/v3_202107300613/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "82754"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Letters to the editor"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/16652681/000000220000000C/v3_202107300613/S1665268121000259/v3_202107300613/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268121000259?idApp=UINPBA00004N"
]